These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22260162)

  • 21. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
    Shman TV; Belevtsev MV; Buglova SE
    Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
    Chen SH
    Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
    Janka-Schaub GE; Harms DO; den Boer ML; Veerman AJ; Pieters R
    Klin Padiatr; 1999; 211(4):233-8. PubMed ID: 10472556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R
    Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Wang Y; Zeng HM; Zhang LP
    Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
    Zwaan CM; Kaspers GJ; Pieters R; Ramakers-Van Woerden NL; den Boer ML; Wünsche R; Rottier MM; Hählen K; van Wering ER; Janka-Schaub GE; Creutzig U; Veerman AJ
    Blood; 2000 Oct; 96(8):2879-86. PubMed ID: 11023525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
    Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo activity of thalidomide in childhood acute leukemia.
    Styczynski J; Czyzewski K; Wysocki M
    Leuk Lymphoma; 2006 Jun; 47(6):1123-8. PubMed ID: 16840205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
    Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
    Eur J Haematol; 1996 Aug; 57(2):134-41. PubMed ID: 8856090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
    Lugthart S; Cheok MH; den Boer ML; Yang W; Holleman A; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
    Cancer Cell; 2005 Apr; 7(4):375-86. PubMed ID: 15837626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).
    Escherich G; Tröger A; Göbel U; Graubner U; Pekrun A; Jorch N; Kaspers G; Zimmermann M; zur Stadt U; Kazemier K; Pieters R; Den Boer ML; Horstmann M; Janka GE;
    Haematologica; 2011 Jun; 96(6):854-62. PubMed ID: 21330320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of glufosfamide in childhood acute leukemia.
    Styczynski J; Wysocki M; Kurylak A; Juraszewska E; Malinowska I; Stanczak E; Płoszynska A; Stefaniak J; Mazur B; Szczepanski T; Ras M
    Anticancer Res; 2002; 22(1A):247-50. PubMed ID: 12017297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia.
    Maung ZT; Reid MM; Matheson E; Taylor PR; Proctor SJ; Hall AG
    Br J Haematol; 1995 Sep; 91(1):93-100. PubMed ID: 7577660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
    Holleman A; Cheok MH; den Boer ML; Yang W; Veerman AJ; Kazemier KM; Pei D; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
    N Engl J Med; 2004 Aug; 351(6):533-42. PubMed ID: 15295046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
    Klumper E; Pieters R; Veerman AJ; Huismans DR; Loonen AH; Hählen K; Kaspers GJ; van Wering ER; Hartmann R; Henze G
    Blood; 1995 Nov; 86(10):3861-8. PubMed ID: 7579354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.
    Pogorzala M; Kubicka M; Rafinska B; Wysocki M; Styczynski J
    Anticancer Res; 2015 Oct; 35(10):5667-70. PubMed ID: 26408741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia.
    Yamada S; Hongo T; Okada S; Watanabe C; Fujii Y; Ohzeki T
    Leukemia; 2001 Dec; 15(12):1892-7. PubMed ID: 11753610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.